A critical breakthrough in cancer study is arising with the use of VHH fragments to restore dysfunctional p53. This vital malignant inhibitor protein is frequently inactivated in many types of malignancies, resulting https://social-medialink.com/story7019102/nanobodies-reactivate-tumor-suppressor-p53-the-promising-pathway-for-cancer-treatment